FDA Approves Cutting-Edge Cancer Drug from Inova Schar Cancer Institute Clinical Trial

dart board with a red dart in the center bulls eye

Inova’s Dr. John Deeken served as the site principal investigator for this prestigious study In groundbreaking news for the medical and cancer research community, the Food and Drug Administration (FDA) approved a new, breakthrough cancer drug, larotrectinib, or Vitrakvi®, that targets specific genetic mutations in adult and pediatric patients. This is only the second tissue-agnostic…

Read More

NPR Visits Inova to Document Infant-Health Research Study

nurse swabbing a newborn baby

Inova’s vaginal seeding study featured on NPR’s Morning Edition NPR’s Morning Edition has profiled the groundbreaking vaginal seeding study at Inova Women’s Hospital that aims to discover if babies born by C-section will benefit from a swab of their mother’s microbes. The article explains how vaginal seeding “was developed in response to the sharp rise…

Read More

The Society for Women’s Health Research Elects Roberta L. Gartside, MD, as Incoming Chair of Its Board of Directors

inova logo

Washington, DC —The Society for Women’s Health Research (SWHR) announced the unanimous election of Roberta L. Gartside, MD, as the new Chair of its Board of Directors for 2018-2019. As a business leader with a strong commitment to nonprofit service, Dr. Gartside will lead the organization’s mission-based efforts to eliminate imbalances in care for women…

Read More

The GALILEO Trial: Inova Researchers Study New Drug Therapy for Heart Patients

Matthew W. Sherwood, MD, is board certified in interventional cardiology, cardiovascular disease and internal medicine. He practices at the Inova Schar Heart and Vascular. Read Dr. Sherwood’s profile. Starting in March, we began enrolling patients in a first-of-its-kind study to compare drug therapies for patients who have had transcatheter aortic valve replacement, or TAVR. As…

Read More

From Research to Results: Advances in Genitourinary Cancer Treatment  

Jeanny B. Aragon-Ching, MD, is the clinical program director of genitourinary cancers at the Inova Schar Cancer Institute. She is board certified in medical oncology, hematology and internal medicine and has a special interest in caring for patients with prostate, bladder, kidney and testicular cancers. Read Dr. Aragon-Ching’s profile.  This February, I’ll be traveling to…

Read More

Fecal Transplants Bring Gut Bacteria Into Balance  

Suchi Hourigan, MD, is board certified in pediatric gastroenterology. She treats children of all ages and has a particular interest in the gut microbiome, nutrition and disorders of the intestines. She’s also the director of microbiome research at the Inova Translational Medicine Institute, where she studies the role of gut bacteria in human health and…

Read More

New Findings in Cancer Immunotherapy: Inova Experts Weigh In

Sekwon Jang, MD, is board certified in medical oncology, hematology and internal medicine. He serves as Inova’s director of Melanoma and Cutaneous Oncology Therapeutics and Research and director of quality at the Inova Schar Cancer Institute. He has a special interest in melanoma and other skin cancers. Read Dr. Jang’s profile. Thomas P. Conrads, PhD, recently…

Read More